Villere ST Denis J & Co. LLC decreased its position in Colgate-Palmolive Company (NYSE:CL – Free Report) by 3.9% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 227,880 shares of the company’s stock after selling 9,275 shares during the period. Colgate-Palmolive makes up approximately 2.1% of Villere ST Denis J & Co. LLC’s holdings, making the stock its 29th biggest position. Villere ST Denis J & Co. LLC’s holdings in Colgate-Palmolive were worth $19,422,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also bought and sold shares of the company. Equitable Trust Co. bought a new stake in shares of Colgate-Palmolive during the first quarter valued at approximately $680,000. Mason & Associates Inc lifted its position in Colgate-Palmolive by 1.7% in the 1st quarter. Mason & Associates Inc now owns 8,493 shares of the company’s stock valued at $728,000 after acquiring an additional 143 shares in the last quarter. Griffin Asset Management Inc. boosted its stake in Colgate-Palmolive by 0.8% during the 1st quarter. Griffin Asset Management Inc. now owns 16,377 shares of the company’s stock valued at $1,396,000 after purchasing an additional 134 shares during the last quarter. Main Street Research LLC increased its holdings in shares of Colgate-Palmolive by 13.1% in the 1st quarter. Main Street Research LLC now owns 7,484 shares of the company’s stock worth $638,000 after purchasing an additional 866 shares in the last quarter. Finally, First Horizon Corp increased its holdings in shares of Colgate-Palmolive by 231.9% in the 1st quarter. First Horizon Corp now owns 45,200 shares of the company’s stock worth $3,852,000 after purchasing an additional 31,583 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors.
Colgate-Palmolive Stock Performance
Colgate-Palmolive stock traded up $1.30 during mid-day trading on Friday, reaching $92.31. 4,257,117 shares of the stock traded hands, compared to its average volume of 4,923,956. Colgate-Palmolive Company has a 12-month low of $74.54 and a 12-month high of $99.33. The business’s 50-day moving average is $89.91 and its 200-day moving average is $88.10. The company has a debt-to-equity ratio of 16.33, a current ratio of 1.02 and a quick ratio of 0.67. The stock has a market capitalization of $73.86 billion, a PE ratio of 35.92, a price-to-earnings-growth ratio of 4.80 and a beta of 0.33.
Colgate-Palmolive Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, August 14th. Shareholders of record on Monday, July 20th will be issued a dividend of $0.53 per share. This represents a $2.12 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date of this dividend is Monday, July 20th. Colgate-Palmolive’s dividend payout ratio is currently 82.49%.
Analyst Upgrades and Downgrades
A number of research analysts have recently issued reports on CL shares. TD Cowen reaffirmed a “hold” rating and set a $85.00 price target on shares of Colgate-Palmolive in a report on Tuesday, March 31st. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a $99.00 target price on shares of Colgate-Palmolive in a research report on Monday, May 4th. Barclays upped their target price on shares of Colgate-Palmolive from $79.00 to $80.00 and gave the company an “equal weight” rating in a research note on Tuesday, May 5th. JPMorgan Chase & Co. raised their price target on shares of Colgate-Palmolive from $95.00 to $96.00 and gave the company an “overweight” rating in a report on Monday, May 4th. Finally, Wall Street Zen cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Sunday, March 29th. Twelve equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $96.29.
Read Our Latest Stock Analysis on Colgate-Palmolive
Colgate-Palmolive Profile
Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.
The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.
Further Reading
- Five stocks we like better than Colgate-Palmolive
- Starbucks Builds Sovereign AI to Cut $400 Million in Software Costs
- Power Struggle: Wolfspeed Sues Navitas Over AI Chips
- Why WD-40 Is Proving Great Businesses Never Go Out of Style
- Pushing the Edge: Super Micro Computer Reboots the AI Landscape
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.
